Article Information
History
- September 18, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Martha Namusobya1,*,
- Felix Bongomin2,3,
- Mukisa John4,
- Ivan Kimuli5,
- Ahmed Ddungu6,
- Charles Batte5 and
- Bruce J. Kirenga5
- 1Department of Clinical Epidemiology and Biostatistics, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda
- 2Department of Medical Microbiology and Immunology, Faculty of Medicine, Gulu University, Gulu, Uganda
- 3Division of Evolution, Infection and Genomics, Faculty of Biology, Medicine and Health, University of Manchester, M13 9PL, Oxford Road, Manchester, United Kingdom
- 4Department of Immunology and Molecular Biology, School of Biomedical Sciences, College of Health Sciences, Makerere University, Kampala, Uganda
- 5Makerere Lung Institute, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda
- 6Infectious Diseases Institute, College of Health Sciences, Makerere University, Kampala, Uganda
- ↵*Correspondence to Dr. Martha Namusobya, Department of Clinical Epidemiology and Biostatistics, School of Medicine, College of Health Sciences, Makerere University, Kampala, Uganda. Email: martharynam{at}gmail.com
Posted September 18, 2023.
Chronic respiratory symptoms and chronic obstructive pulmonary disease following completion of pulmonary tuberculosis treatment in Uganda
